Search results

NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .

Result type

Medtech innovation briefing

Published

10 May 2022

NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .

Result type

Medtech innovation briefing

Published

17 December 2019

NICE has developed a medtech innovation briefing (MIB) on CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease .

Result type

Medtech innovation briefing

Published

4 March 2019

NICE has developed a medtech innovation briefing (MIB) on Prevena incision management system for closed surgical incisions .

Result type

Medtech innovation briefing

Published

28 February 2019

Advice on the use of Cellvizio confocal endomicroscopy system (CLS) for characterising pancreatic cysts to aid local decision-making

Result type

Medtech innovation briefing

Published

28 June 2016

NICE has developed a medtech innovation briefing (MIB) on ClearWay RX for drug delivery to coronary artery thrombotic lesions

Result type

Medtech innovation briefing

Published

11 March 2016

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures in adults. This involves using an ultrasound probe on the skin at the site of the fracture.

Result type

Interventional procedures guidance

Published

31 July 2018

Evidence-based recommendations on transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain in adults. This involves delivering focused ultrasound to a small part of the brain (in the thalamus) responsible for transmitting pain signals to destroy it.

Result type

Interventional procedures guidance

Published

28 November 2018

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing in adults. This involves using an ultrasound probe on the skin at the site of the fracture.

Result type

Interventional procedures guidance

Published

31 July 2018

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing in adults. This involves using an ultrasound probe on the skin at the site of the fracture.

Result type

Interventional procedures guidance

Published

31 July 2018

Evidence-based recommendations on single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity. This involves reducing the size of the stomach and small intestine to reduce the amount of food absorbed.

Result type

Interventional procedures guidance

Published

23 November 2016

Evidence-based recommendations on insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. The catheter aims to help induction by causing dilation of the cervix when the cervix is unfavourable for induction. The double balloon squeezes the cervix and stimulates local prostaglandin release, which leads to cervical ripening.

Result type

Interventional procedures guidance

Published

23 July 2015

Evidence-based recommendations on intravascular lithotripsy for calcified arteries in peripheral arterial disease. This involves using pressure waves to soften arterial plaque and widen the artery to improve blood flow.

Result type

Interventional procedures guidance

Published

3 January 2024

In January 2008, Pfizer ceased production of its inhaled insulin product Exubera. NICE technology appraisal 113 on inhaled insulin for diabetes (types I and II) has therefore been made obsolete. Pfizer have been letting doctors know that they should begin moving their patients off Exubera and onto other medicines that control high blood sugar levels. If you are worried about how you should control your blood sugar levels as a result of this announcement, you should contact your doctor as soon as possible to discuss your options for other blood sugar lowering medications. 25 January 2008

Result type

Technology appraisal guidance

Published

13 December 2006

Evidence-based recommendations on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy. This involves removing parts of the pancreas (islet cells) after the pancreas has been removed and inserting them into the liver to restart insulin production.

Result type

Interventional procedures guidance

Published

24 September 2008